Page 22 - ட்ரெக்செல் பல்கலைக்கழகம் கல்லூரி ஆஃப் மருந்து News Today : Breaking News, Live Updates & Top Stories | Vimarsana

CDC Advisers Reaffirm Backing of J&J’s Vaccine After Pause Bloomberg 1 hr ago Angelica LaVito and Riley Griffin (Bloomberg) A panel of medical experts reaffirmed their support for Johnson & Johnson’s Covid-19 vaccine, setting the stage for regulators to allow use of the shot to resume after a pause to study rare, severe blood clots in some recipients. The Advisory Committee on Immunization Practices voted 10 to 4, with one abstention, to back the vaccine, opening the way for the U.S. Centers for Disease Control and Prevention and the Food and Drug Administration to lift the hold on the shot. Regulators put dosing on hold 10 days ago to gather more information about the side effect.

United statesRochelle walenskySarah longJohnson covidBiden teamDrexel university college of medicineUs centers for diseaseDrug administrationAdvisory committee on immunization practicesAstrazeneca plcPfizer incEuropean unionEuropean medicines agencyModerna incAdvisory committeeImmunization practices